Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Down | Down |
| Historical EPRX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 2.05% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 2.05% | |
| Lower Bollinger Band Walk | Weakness | 2.05% | |
| Stochastic Reached Oversold | Weakness | 2.05% | |
| Outside Day | Range Expansion | 2.05% | |
| Lower Bollinger Band Touch | Weakness | 2.05% | |
| Oversold Stochastic | Weakness | 2.05% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. | |
Get a Trading Assistant
- Earnings date: ???
Eupraxia Pharmaceuticals Inc Description
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate, EP-104IAR, that is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treatment of canine and equine osteoarthritis. Its products in development also include EP-201, a product candidate for prophylaxis of post-surgical infections; and EP-105, an extended-release product candidate for the local delivery of anesthetics to treat post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was founded in 2012 and is headquartered in Victoria, Canada.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pain Biotechnology Life Sciences Arthritis Osteoarthritis Skeletal Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.19 |
| 52 Week Low | 1.9 |
| Average Volume | 19,036 |
| 200-Day Moving Average | 0.000 |
| 50-Day Moving Average | 2.352 |
| 20-Day Moving Average | 2.083 |
| 10-Day Moving Average | 2.029 |
| Average True Range | 0.123 |
| ADX | 12.34 |
| +DI | 23.046 |
| -DI | 22.565 |
| Chandelier Exit (Long, 3 ATRs) | 2.030 |
| Chandelier Exit (Short, 3 ATRs) | 2.270 |
| Upper Bollinger Bands | 2.247 |
| Lower Bollinger Band | 1.919 |
| Percent B (%b) | 0.22 |
| BandWidth | 15.718 |
| MACD Line | -0.102 |
| MACD Signal Line | -0.109 |
| MACD Histogram | 0.0064 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.125 | ||||
| Resistance 3 (R3) | 2.110 | 2.050 | 2.103 | ||
| Resistance 2 (R2) | 2.050 | 2.016 | 2.058 | 2.095 | |
| Resistance 1 (R1) | 2.020 | 1.994 | 2.035 | 2.035 | 2.087 |
| Pivot Point | 1.960 | 1.960 | 1.968 | 1.968 | 1.960 |
| Support 1 (S1) | 1.930 | 1.926 | 1.945 | 1.945 | 1.893 |
| Support 2 (S2) | 1.870 | 1.904 | 1.878 | 1.885 | |
| Support 3 (S3) | 1.840 | 1.870 | 1.878 | ||
| Support 4 (S4) | 1.855 |
